Advanced search
Showing results 6501 to 6520 on 8144 in total
-
ade4: Analysis of Ecological Data: Exploratory and Euclidean Methods in Environmental Sciences
Stéphane Dray, Anne-Béatrice Dufour, Jean Thioulouse, Aurélie Siberchicot, Thibaut Jombart, Sandrine Pavoine, Jean R. Lobry, Sébastien Ollier, Daniel Borcard, Pierre Legendre, Stéphanie Bougeard, Daniel Chessel.
-
Supervised Multiblock Analysis in R with the ade4 Package
Stéphanie Bougeard, Stéphane Dray
-
Analyse de (K+1) tableaux avec le logiciel ade4. Application en épidémiologie.
Stéphanie Bougeard, Stéphane Dray
-
Estimating individualized treatment effects using an individual participant data meta-analysis
Florie Bouvier, Anna Chaimani, Etienne Peyrot, François Gueyffier, Guillaume Grenet, Raphaël Porcher
-
Fondamentaux de l’évaluation des thérapeutiques, médicamenteuses et non médicamenteuses – un cadre pour l’évaluation des processus d’autoguérison
François Gueyffier, Rémy Boussageon
-
Diabetes, periodontitis, and cardiovascular disease: towards equity in diabetes care
Constanza Serón, Pablo Olivero, Nicolás Flores, Benjamín Cruzat, Francisca Ahumada, François Gueyffier, Ivanny Marchant
-
Pharmacokinetic/pharmacodynamic model of a methionine starvation based anti-cancer drug
N. Eymard, N. Bessonov, V. Volpert, P. Kurbatova, F. Gueyffier, P. Nony
-
Effect of periodontal treatment on the glomerular filtration rate, reduction of inflammatory markers and mortality in patients with chronic kidney disease: A systematic review
T. Delbove, F. Gueyffier, L. Juillard, E. Kalbacher, D. Maucort-Boulch, P. Nony, B. Grosgogeat, K. Gritsch
-
Impact of terminating reimbursement of symptomatic slow-acting drugs in osteoarthritis in France on volume and cost of drug deliveries, assessed with administrative databases
K. Mari, F. Rannou, F. Guillemin, M. Elegbede, F. Gueyffier, G. Badot, F. Mistretta
-
Dynamical modeling of pro- and anti-inflammatory cytokines in the early stage of septic shock
J. Tallon, B. Browning, F. Couenne, C. Bordes, F. Venet, P. Nony, F. Gueyffier, V. Moucadel, G. Monneret, M. Tayakout-Fayolle
-
High Risk versus Proportional Benefit: Modelling Equitable Strategies in Cardiovascular Prevention
I. Marchant, Jp. Boissel, Patrice Nony, F. Gueyffier
-
Is HbA a valid surrogate for macrovascular and microvascular complications in type 2 diabetes?
T. Bejan-Angoulvant, Catherine Cornu, P. Archambault, B. Tudrej, P. Audier, Y. Brabant, F. Gueyffier, R. Boussageon
-
Is legacy a myth or a reality? We should know, and we do not
F. Gueyffier, Michel Cucherat
-
Can we identify response markers to antihypertensive drugs? First results from the Ideal Trial.
Gueyffier F., Subtil F., Bejan-Angoulvant T., Yves Zerbib, Baguet Jp, Boivin Jm, Mercier A., Leftheriotis G., Gagnol Jp, Fauvel Jp, Giraud C., Bricca G., Delphine Maucort-Boulch, Erpeldinger S
-
Information et participation active des patients à l\textquoterightaide d\textquoterightune brochure interactive lors de la prescription d\textquoterightantihypertenseurs en soins primaires
M. Keriel-Gascou, A. Badet-Phan, Ma. Le Pogam, S. Figon, L. Letrilliart, F. Gueyffier, C. Chanelière, K. Buchet-Poyau, A. Duclos, C. Colin
-
Approche individu-centrée pour l'exploration de stratégies de prescription médicale - un exemple dans l'hypertension artérielle
Nadia Abchiche-Mimouni, Monique Rousset, F. Gueyffier
-
Virtual reality exposure therapy versus cognitive behavior therapy for panic disorder with agoraphobia: a randomized comparison study
A. Pelissolo, M. Zaoui, G. Aguayo, S. Nan Yao, S. Roche, René Ecochard, F. Gueyffier, C. Pull, A. Berthoz, R. Jouvent, J. Cottraux
-
51 – Existe-t-il une surmortalité chez les femmes dépistées par mammographie ? Méta-analyse sur la mortalité non liée au cancer du sein
L. Fayolle, F. Gueyffier, S. Erpeldinger
-
Heterogeneity prevails: the state of clinical trial data management in Europe - results of a survey of ECRIN centres
W. Kuchinke, C. Ohmann, Q. Yang, N. Salas, J. Lauritsen, F. Gueyffier, Alain Leizorovicz, C. Schade-Brittinger, M. Wittenberg, Z. Voko, S. Gaynor, M. Cooney, P. Doran, A. Maggioni, A. Lorimer, F. Torres, G. Mcpherson, J. Charwill, M. Hellstrom, S. Lejeune
-
Critique du modèle additif de l'essai clinique randomisé
R. Boussageon, F. Gueyffier, T. Bejan-Angoulvant, Géraldine Felden